Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,864 | -1,542 | -5,263 | -3,569 | -11,135 |
| Accounts receivable | N/A | N/A | 96 | 96 | 96 |
| Accounts payable and accrued liabilities | -547 | -456 | -1,772 | -2,157 | -1,106 |
| Other Working Capital | -478 | -510 | -4,601 | -4,651 | -2,439 |
| Other Operating Activity | 912 | 637 | -9,705 | -9,423 | 1,815 |
| Operating Cash Flow | $-2,977 | $-1,871 | $-21,245 | $-19,704 | $-12,769 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 10,402 | 10,402 | 0 |
| Investing Cash Flow | $N/A | $N/A | $10,402 | $10,402 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 24 | 24 | 24 |
| Common Stock Repurchased | N/A | N/A | 5,000 | 5,000 | 5,000 |
| Financing Cash Flow | $N/A | $N/A | $5,024 | $5,024 | $5,024 |
| Exchange Rate Effect | -6 | -4 | 8 | 4 | 4 |
| Beginning Cash Position | 7,571 | 7,571 | 13,382 | 13,382 | 13,382 |
| End Cash Position | 4,588 | 5,696 | 7,571 | 9,108 | 5,641 |
| Net Cash Flow | $-2,983 | $-1,875 | $-5,811 | $-4,274 | $-7,741 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,977 | -1,871 | -21,245 | -19,704 | -12,769 |
| Free Cash Flow | -2,977 | -1,871 | -21,245 | -19,704 | -12,769 |